RARE - X Explores Patient - Owned Data Gathering for Cell and Gene Therapy Developers
Scientists are being urged to use a non- proprietary data collection platform to ensure they can gather the data needed by stakeholders, according to researchers at the American Institute for Cell and Gene Medicine (AIMOS). Why? A new white paper explores the primary issues facing cell and gene therapy developers.
Source: prweb.comPublished on 2021-03-30
Related news
- Open platform : The idea of digital ecosystems
- Albcontrol , Red Flag For Tenders , Over 1 Billion ALL Given Without Competition , No Investigation By The Prosecution
- Why an open platform is ideal for the digital banking ecosystem
- World Bank approves US$450m loan to support key governance reforms in Morocco
- European Structural and Investment Funds : spending doubled in 2019 - 2020
- Microsoft CEO Satya Nadella talks regulation , hiring and expansion in Canada
- UAE : Officials to start visiting homes for biggest Sharjah Census from October 20
- RARE - X Announces Formation of Corporate Advisory Council
- Telefnica forms a posse to push industrial AI in Spain
- Independent Software Vendors ( ISVs ) Market : Comprehensive Study COVID19 Impact Analysis and Forecast Outlook 2019 - 2027
- Awesense and vadimUS Launch Unique Platform to Address Nanogrid Challenges in the Electrical Grid
- Microsoft CEO Satya Nadella talks regulation , hiring and expansion in Canada - PLANT
- How to delete or deactivate your Apple ID account
- RARE - X And CoRDS Collaborate To Improve Patient Outcomes For Rare Diseases
- Crown rejects Blackstone offer